BlackRock, Inc.
$172.11B- Market cap
- $170.81B
- Debt
- +$12.77B
- Cash
- −$11.47B
Capital structure 93% equity / 7% debt · EV / Revenue 7.11x · EV / EBITDA 21.90x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $170.81B · View financials
Snapshot Sep 8, 2026, 2:10 PM ET
FY 2025 ·
Decision snapshot: BLK stock price at discount vs GDRX $1.10K current versus $1.39K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GDRX's multiple
Implied fair value · at BLK's multiple
Snapshot Sep 8, 2026, 2:10 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BLK FY 2025 (ended Dec 31, 2025) · GDRX FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 93% equity / 7% debt · EV / Revenue 7.11x · EV / EBITDA 21.90x
Capital structure 71% equity / 29% debt · EV / Revenue 1.81x · EV / EBITDA 7.67x
BLK carries the larger enterprise value at $172.11B against $1.44B; GDRX trades on the lower EV / Revenue multiple (1.81x vs 7.11x); GDRX on the lower EV / EBITDA (7.67x vs 21.90x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BlackRock, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
GoodRx Holdings, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.23x
0.81x
Net debt / EBITDA
Leverage against operating earnings
0.17x
1.26x
Cash and equivalents
Liquid reserves on the balance sheet
$11.47B
$261.82M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
STATE STREET CORP
BLK vs STT
NORTHERN TRUST CORP
BLK vs NTRS
PRICE T ROWE GROUP INC
BLK vs TROW
The Goldman Sachs Group, Inc.
BLK vs GS
Morgan Stanley
BLK vs MS
Blackstone Inc.
BLK vs BX
Evolent Health, Inc.
BLK vs EVH
CVS HEALTH Corp
BLK vs CVS
Doximity, Inc.
BLK vs DOCS
Criteo S.A.
BLK vs CRTO
$12.77B
$500.00M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.